Literature DB >> 28003081

Transitional B cell subsets-a convincing predictive biomarker for allograft loss?

Hannah Burton1, Anthony Dorling2.   

Abstract

In this issue, Cherukuri and colleagues describe a convincing association between the proportion of transitional B lymphocyte subsets in kidney transplant recipients and long-term outcomes, and present a biologically plausible mechanism, based on differential ability of T1 and T2 cells to regulate in vitro T cell responses to explain the link. Further work is clearly needed to validate their claim that measurement of T1/T2 ratios may represent a reliable and reproducible predictive biomarker of transplant outcomes.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28003081     DOI: 10.1016/j.kint.2016.10.028

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  Elevated number of IL-21+ TFH and CD86+CD38+ B cells in blood of renal transplant recipients with AMR under conventional immuno-suppression.

Authors:  Jing Liu; Tongyu Tang; Zhihui Qu; Li Wang; Rui Si; Haifeng Wang; Yanfang Jiang
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

2.  Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation.

Authors:  Yakov A Lomakin; Ivan V Zvyagin; Leyla A Ovchinnikova; Marsel R Kabilov; Dmitriy B Staroverov; Artem Mikelov; Alexey E Tupikin; Maria Y Zakharova; Nadezda A Bykova; Vera S Mukhina; Alexander V Favorov; Maria Ivanova; Taras Simaniv; Yury P Rubtsov; Dmitriy M Chudakov; Maria N Zakharova; Sergey N Illarioshkin; Alexey A Belogurov; Alexander G Gabibov
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 3.  Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases.

Authors:  Yang Zhou; Ying Zhang; Jinming Han; Mengge Yang; Jie Zhu; Tao Jin
Journal:  J Transl Med       Date:  2020-03-17       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.